State Street’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $170M | Sell |
6,863,060
-44,562
| -0.6% | -$1.06M | 0.01% | 1035 |
|
|
2025
Q4 | $161M | Buy |
6,907,622
+502,235
| +8% | +$11.2M | 0.01% | 1076 |
|
|
2025
Q3 | $126M | Buy |
6,405,387
+926,999
| +17% | +$19.1M | ﹤0.01% | 1208 |
|
|
2025
Q2 | $119M | Sell |
5,478,388
-52,049
| -0.9% | -$1.23M | ﹤0.01% | 1211 |
|
|
2025
Q1 | $134M | Sell |
5,530,437
-266,123
| -5% | -$5.99M | 0.01% | 1114 |
|
|
2024
Q4 | $121M | Buy |
5,796,560
+111,230
| +2% | +$2.39M | ﹤0.01% | 1232 |
|
|
2024
Q3 | $113M | Sell |
5,685,330
-347,968
| -6% | -$6.45M | ﹤0.01% | 1261 |
|
|
2024
Q2 | $93.5M | Sell |
6,033,298
-2,119,604
| -26% | -$33M | ﹤0.01% | 1306 |
|
|
2024
Q1 | $130M | Buy |
8,152,902
+1,365,570
| +20% | +$20.6M | 0.01% | 1147 |
|
|
2023
Q4 | $114M | Sell |
6,787,332
-783,363
| -10% | -$10.7M | 0.01% | 1215 |
|
|
2023
Q3 | $88.5M | Sell |
7,570,695
-1,882,382
| -20% | -$25.2M | ﹤0.01% | 1265 |
|
|
2023
Q2 | $127M | Buy |
9,453,077
+1,910,359
| +25% | +$27.5M | 0.01% | 1065 |
|
|
2023
Q1 | $125M | Sell |
7,542,718
-330,596
| -4% | -$5.45M | 0.01% | 1042 |
|
|
2022
Q4 | $146M | Buy |
7,873,314
+317,891
| +4% | +$4.89M | 0.01% | 931 |
|
|
2022
Q3 | $96.9M | Buy |
7,555,423
+2,117,944
| +39% | +$25.1M | 0.01% | 1116 |
|
|
2022
Q2 | $38.1M | Buy |
5,437,479
+819,524
| +18% | +$6.01M | ﹤0.01% | 1828 |
|
|
2022
Q1 | $38.3M | Sell |
4,617,955
-433,034
| -9% | -$3.06M | ﹤0.01% | 1925 |
|
|
2021
Q4 | $34.2M | Sell |
5,050,989
-1,018,392
| -17% | -$6.7M | ﹤0.01% | 2084 |
|
|
2021
Q3 | $32.2M | Buy |
6,069,381
+70,933
| +1% | +$388K | ﹤0.01% | 2135 |
|
|
2021
Q2 | $34.5M | Sell |
5,998,448
-2,935,535
| -33% | -$15.1M | ﹤0.01% | 2123 |
|
|
2021
Q1 | $41.2M | Buy |
8,933,983
+2,820,053
| +46% | +$11.2M | ﹤0.01% | 1887 |
|
|
2020
Q4 | $20.4M | Sell |
6,113,930
-1,518,422
| -20% | -$5.1M | ﹤0.01% | 2227 |
|
|
2020
Q3 | $22.7M | Buy |
7,632,352
+955,751
| +14% | +$3.74M | ﹤0.01% | 1967 |
|
|
2020
Q2 | $30.8M | Sell |
6,676,601
-764,221
| -10% | -$3.43M | ﹤0.01% | 1764 |
|
|
2020
Q1 | $28.6M | Buy |
7,440,822
+22,527
| +0.3% | +$92.5K | ﹤0.01% | 1602 |
|
|
2019
Q4 | $27.8M | Buy |
7,418,295
+3,791,669
| +105% | +$17.7M | ﹤0.01% | 1905 |
|
|
2019
Q3 | $19.3M | Buy |
3,626,626
+1,805,435
| +99% | +$9.62M | ﹤0.01% | 2091 |
|
|
2019
Q2 | $6.99M | Buy |
1,821,191
+194,096
| +12% | +$838K | ﹤0.01% | 2653 |
|
|
2019
Q1 | $8.3M | Buy |
1,627,095
+71,118
| +5% | +$209K | ﹤0.01% | 2551 |
|
|
2018
Q4 | $2.99M | Buy |
1,555,977
+28,527
| +2% | +$81.7K | ﹤0.01% | 2953 |
|
|
2018
Q3 | $5.77M | Buy |
1,527,450
+88,522
| +6% | +$277K | ﹤0.01% | 2792 |
|
|
2018
Q2 | $4.49M | Buy |
1,438,928
+235,288
| +20% | +$714K | ﹤0.01% | 2916 |
|
|
2018
Q1 | $2.88M | Buy |
1,203,640
+65,842
| +6% | +$219K | ﹤0.01% | 3031 |
|
|
2017
Q4 | $4.45M | Buy |
1,137,798
+193,503
| +20% | +$639K | ﹤0.01% | 2841 |
|
|
2017
Q3 | $2.38M | Buy |
944,295
+6,100
| +0.7% | +$16.7K | ﹤0.01% | 3126 |
|
|
2017
Q2 | $2.59M | Buy |
938,195
+892,895
| +1,971% | +$1.86M | ﹤0.01% | 3026 |
|
|
2017
Q1 | $88K | Hold |
45,300
| – | – | ﹤0.01% | 3547 |
|
|
2016
Q4 | $47K | Hold |
45,300
| – | – | ﹤0.01% | 3565 |
|
|
2016
Q3 | $49K | Hold |
45,300
| – | – | ﹤0.01% | 3486 |
|
|
2016
Q2 | $33K | Sell |
45,300
-1,148,674
| -96% | -$925K | ﹤0.01% | 3622 |
|
|
2016
Q1 | $1.4M | Buy |
1,193,974
+61,345
| +5% | +$95.2K | ﹤0.01% | 3122 |
|
|
2015
Q4 | $2.78M | Buy |
1,132,629
+102,198
| +10% | +$293K | ﹤0.01% | 2861 |
|
|
2015
Q3 | $3.1M | Buy |
1,030,431
+369,172
| +56% | +$1.59M | ﹤0.01% | 2785 |
|
|
2015
Q2 | $2.73M | Buy |
661,259
+616,859
| +1,389% | +$2.46M | ﹤0.01% | 2939 |
|
|
2015
Q1 | $193K | Hold |
44,400
| – | – | ﹤0.01% | 3497 |
|
|
2014
Q4 | $133K | Sell |
44,400
-5,000
| -10% | -$13.7K | ﹤0.01% | 3532 |
|
|
2014
Q3 | $164K | Buy |
49,400
+2,200
| +5% | +$5.75K | ﹤0.01% | 3494 |
|
|
2014
Q2 | $120K | Hold |
47,200
| – | – | ﹤0.01% | 3454 |
|
|
2014
Q1 | $107K | Hold |
47,200
| – | – | ﹤0.01% | 3502 |
|
|
2013
Q4 | $92K | Buy |
+47,200
| New | +$95.4K | ﹤0.01% | 3491 |
|
Other funds holding CPRX
VCM
DM
VPM
State Street's CPRX Position: Q1 2026 in Review
State Street reduced its Catalyst Pharmaceutical (CPRX) stake by 0.65% in Q1 2026, selling an estimated $1.06M and leaving 6,863,060 shares worth $170M. The position accounts for 0.01% of the portfolio, ranked #1035.
State Street first reported a position in CPRX in Q4 2013 and has held it in 50 quarters since. 380 funds tracked by Wall St. Rank hold CPRX as of Q1 2026.
- State Street held 6,863,060 shares of Catalyst Pharmaceutical worth $170M as of Q1 2026.
- State Street sold 44,562 Catalyst Pharmaceutical shares in Q1 2026, an estimated $1.06M.
- Catalyst Pharmaceutical made up 0.01% of State Street's portfolio in Q1 2026, its #1035 holding.
- State Street first reported a position in Catalyst Pharmaceutical in Q4 2013 and has held it in 50 quarters since.
- 380 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q1 2026.
Based on State Street's 13F filing for Q1 2026, filed 15 May 2026.